 | Up a level |
Gisondi, P; Cazzaniga, S; Di Leo, S; Piaserico, S; Bellinato, F; Pizzolato, M; Gatti, A; Eccher, A; Brunelli, M; Saraggi, D; Girolomoni, G; Naldi, L (2021). Impact of the COVID-19 pandemic on melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(11), e714-e715. Wiley 10.1111/jdv.17493
Piaserico, S; Gisondi, P; Cazzaniga, S; Girolomoni, G; Calzavara-Pinton, P G; Naldi, L (2021). Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? Journal of the European Academy of Dermatology and Venereology : JEADV, 35(6), e355-e357. Wiley 10.1111/jdv.17175
Nast, A; Smith, C; Spuls, P I; Avila Valle, G; Bata-Csörgö, Z; Boonen, H; De Jong, E; Garcia-Doval, I; Gisondi, P; Kaur-Knudsen, D; Mahil, S; Mälkönen, T; Maul, J T; Mburu, S; Mrowietz, U; Reich, K; Remenyik, E; Rønholt, K M; Sator, P G; Schmitt-Egenolf, M; ... (2021). EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specific clinical and comorbid situations. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(2), pp. 281-317. Wiley 10.1111/jdv.16926
Gisondi, P; Facheris, P; Dapavo, P; Piaserico, S; Conti, A; Naldi, L; Cazzaniga, S; Malagoli, P; Costanzo, A (2020). The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. The British journal of dermatology, 183(2), pp. 373-374. Wiley 10.1111/bjd.19158
Nast, A; Gisondi, P; Ormerod, A D; Saiag, P; Smith, C; Spuls, P I; Arenberger, P; Bachelez, H; Barker, J; Dauden, E; de Jong, E M; Feist, E; Jacobs, A; Jobling, R; Kemény, L; Maccarone, M; Mrowietz, U; Papp, K A; Paul, C; Reich, K; ... (2015). European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC. Journal of the European Academy of Dermatology and Venereology, 29(12), pp. 2277-2294. Blackwell 10.1111/jdv.13354
Mrowietz, U; Kragballe, K; Reich, K; Spuls, P; Griffiths, C E M; Nast, A; Franke, J; Antoniou, C; Arenberger, P; Balieva, F; Bylaite, M; Correia, O; Daudén, E; Gisondi, P; Iversen, L; Kemény, L; Lahfa, M; Nijsten, T; Rantanen, T; Reich, A; ... (2011). Definition of treatment goals for moderate to severe psoriasis: a European consensus. Archives of dermatological research, 303(1), pp. 1-10. Berlin: Springer 10.1007/s00403-010-1080-1
